Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials

Background GLP-1 receptor agonists (GLP-1 RAs) have emerged as an effective therapeutic class for weight loss. However, the efficacy of these agents in reducing cardiovascular endpoints among patients living with obesity or overweight is unclear. Methods We conducted a systematic review and meta-ana...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of cardiovascular drugs : drugs, devices, and other interventions devices, and other interventions, 2024-07, Vol.24 (4), p.509-521
Hauptverfasser:	de Oliveira Almeida, Gustavo, Nienkötter, Thiago Faraco, Balieiro, Caroline Cristine Almeida, Pasqualotto, Eric, Cintra, Júlia Braga, Carvalho, Henrique Champs Porfírio, Silva, Ana Laura Soares, Kabariti, Júlia Camargo, Minucci, Bárbara Silvestre, Bertoli, Edmundo Damiani, Guida, Camila Mota
Format:	Artikel
Sprache:	eng
Schlagworte:	Angina pectoris Bias Blood pressure Cardiac arrhythmia Cardiology Clinical trials CRD CRD42023475226 Diabetes GLP-1 receptor agonists Glucagon Heart attacks Medicine Medicine & Public Health Meta-analysis Obesity Overweight Peptides Pharmacology/Toxicology Pharmacotherapy Sensitivity analysis Stroke Systematic Review Thrombosis Veins & arteries Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!